{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-135860","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.233751+00:00","generated_at":"2026-05-19T22:06:45.901585+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Amylyx shareholders elect three Class I directors; ratify Deloitte; approve say-on-pay proposal","bullets":["Karen Firestone, Justin Klee, and Bernhardt Zeiher elected as Class I directors for term ending 2028. Firestone and Zeiher each had ~21.3M votes withheld; Klee had 1.5M.","Ratification of Deloitte & Touche as auditor for FY 2025 passed with 72.5M for vs 34.7K against.","Non-binding advisory vote on executive compensation passed with 33.1M for, 24.1M against, and 2.0M abstentions.","Total shares voted: ~72.5M on auditor proposal; broker non-votes of 15.4M on director elections and say-on-pay."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-135860","json":"https://secwatch.observer/filing/0001193125-25-135860.json","markdown":"https://secwatch.observer/filing/0001193125-25-135860.md","text":"https://secwatch.observer/filing/0001193125-25-135860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/0001193125-25-135860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/d920336d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:06:45.901585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}